21. Will that Be Cash...or Check?

Welcome back to the cerebral frontlines in this latest episode of Tapping Into Uncomfortable—where intellect meets irreverence and curiosity punches comfort zones square in the Broca's area. In this penultimate episode for the season, Dr. Hubert takes us from animal-bite weight loss skits to the very real science behind GLP-1 drugs. We learn how modern weight-loss meds found unlikely inspiration in reptilian chemistry—tracing it all back to the venomous Gila monster., only to ignite a pharmaceutical arms race and billion-dollar lawsuits with compound pharmacies. The episode then widens its lens to the absurd scale of American healthcare spending, asking: Why are we spending more and living worse than other wealthy nations? From private insurance pitfalls to venture capital's takeover of medical clearinghouses, it's a raw audit of a system that's more about cash and checks than care and cures. Also on the table: "prescriptionism"—a term coined to challenge our overreliance on pills over personal responsibility. What if healing came from the inside out, not from Big Pharma in? With one eye on biology and the other on belief systems, this episode boldly reframes what it means to be well. Key Takeaways: The origins of GLP-1 weight loss drugs lie in the venom of a desert lizard. U.S. healthcare spends more than Japan's GDP annually—with questionable results. Venture capital's role in healthcare billing adds profit layers to pain points. "Prescriptionism" critiques our over-dependence on medication over mindset. Plus, as we near the season finale before a much-needed fishing break, Dr. Hubert reflects on autonomy, imperfection, and why the next revolution in health might start within. Want to keep questioning the system? You're in the right place. www.tappingintouncomfortable.com